The localized scleroderma skin severity index and physician global assessment of disease activity: A work in progress toward development of localized scleroderma outcome measures

Journal of Rheumatology

Volumn 36, Issue 12, 2009, Pages 2819-2829

  Arkachaisri, Thaschawee ^a   Vilaiyuk, Soamarat ^b   Li, Suzanne ^d   O'Neil, Kathleen M ^e   Pope, Elena ^f   Higgins, Gloria C ^g   Punaro, Marilynn ^h   Rabinovich, Egla C ⁱ   Rosenkranz, Margalit ^b   Kietz, Daniel A ^b   Rosen, Paul ^b   Spalding, Steven J ^j   Hennon, Teresa R ^b   Torok, Kathryn S ^b   Cassidy, Elaine ^b   Medsger Jr , Thomas A ^c  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g OHIO STATE UNIVERSITY   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

^j LERNER RESEARCH INSTITUTE   (United States)

more..

Author keywords

Global assessment; Localized scleroderma; Outcome measure; Quality of life; Skin scores

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDREN'S DERMATOLOGY LIFE QUALITY INDEX; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CONTENT VALIDITY; CUTANEOUS PARAMETERS; DERMATOLOGY; DISEASE ACTIVITY; DISEASE DURATION; ERYTHEMA; FEMALE; HUMAN; INTERRATER RELIABILITY; INTRARATER RELIABILITY; LOCALIZED SCLERODERMA; LOCALIZED SCLERODERMA SKIN SEVERITY INDEX; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SCLERODERMA; SCORING SYSTEM; SKIN DISEASE;

ADOLESCENT; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIANS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SCLERODERMA, LOCALIZED; SEVERITY OF ILLNESS INDEX; SKIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 72449194883     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.081284     Document Type: Article

References (54)

1. Torres JE, Sanchez JL. Histopathologic differentiation between localized and systemic scleroderma. Am J Dermatopathol 1998;20:242-245
2. Peterson LS, Nelson AM, Su WP, Mason T, O'Fallon WM, Gabriel SE. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol 1997;24:73-80.
3. Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma). Mayo Clin Proc 1995;70:1068-1076
4. Marzano AV, Menni S, Parodi A, Borghi A, Fuligni A, Fabbri P, et al. Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Eur J Dermatol 2003;13:171-176 (Pubitemid 36428363)
5. Zulian F, Athreya BH, Laxer R, Nelson AM, Feitosa de Oliveira SK, Punaro MG, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology 2006;45:614-620
6. Birdi N, Shore A, Rush P, Laxer RM, Silverman ED, Krafchik B. Childhood linear scleroderma: a possible role of thermography for evaluation. J Rheumatol 1992;19:968-973
7. Hoffmann K, El-Gammal S, Gerbaulet U, Schatz H, Altmeyer P. Examination of circumscribed scleroderma using 20-MHz B-scan ultrasound. In: Altmeyer P, El-Gammal S, Hoffmann K, editors. Ultrasound in dermatology. Berlin, Heidelberg: Springer-Verlag; 1992:231-243
8. Li SC, Liebling MS, Haines KA. Ultrasonography is a sensitive tool for monitoring localized scleroderma. Rheumatology 2007;46:1316-1319
9. Martini G, Murray KJ, Howell KJ, Harper J, Atherton D, Woo P, et al. Juvenile-onset localized scleroderma activity detection by infrared thermography. Rheumatology 2002;41:1178-1182 (Pubitemid 35203548)
10. Weibel L, Howell KJ, Visentin MT, Rudiger A, Denton CP, Zulian F, et al. Laser Doppler flowmetry for assessing localized scleroderma in children. Arthritis Rheum 2007;56:3489-3495 (Pubitemid 47585445)
11. Arkachaisri T, Pino S. Localized scleroderma severity index and global assessments: a pilot study of outcome instruments. J Rheumatol 2008;35:650-657
12. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997;136:305-314 (Pubitemid 27105848)
13. Holme SA, Man I, Sharpe JL, Dykes PJ, Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index: validation of the cartoon version. Br J Dermatol 2003;148:285-290 (Pubitemid 36278970)
14. Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995;132:942-949
15. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174
16. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45:255-268
17. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-428
18. Polit DF, Beck CT, Owen SV. Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health 2007;30:459-467
19. Carmines EG, Zeller RA. Reliability and validity assessment. Lewis-Beck MS, editor. Thousand Oaks, CA: Sage Publications, Inc.; 1979.
20. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 3rd ed. New York: Oxford University Press; 2003.
21. Beaton DE, Hogg-Johnson S, Bombardier C. Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. J Clin Epidemiol 1997;50:79-93. (Pubitemid 27089210)
22. Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992;30:917-925
23. Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1985;28:542-547
24. Cosnes A, Anglade MC, Revuz J, Radier C. Thirteen-megahertz ultrasound probe: its role in diagnosing localized scleroderma. Br J Dermatol 2003;148:724-729 (Pubitemid 36629751)
25. Seidenari S, Conti A, Pepe P, Giannetti A. Quantitative description of echographic images of morphea plaques as assessed by computerized image analysis on 20 MHz B-scan recordings. Acta Derm Venereol 1995;75:442-445 (Pubitemid 26051890)
26. Serup J. Ten years' experience with high-frequency ultrasound examination of the skin: development and refinement of technique and equipment. In: Altmeyer P, El-Gammal S, Hoffmann K, editors. Ultrasound in dermatology. Berlin, Heidelberg: Springer-Verlag; 1992:41-54.
27. Szymanska E, Nowicki A, Mlosek K, Litniewski J, Lewandowski M, Secomski W, et al. Skin imaging with high frequency ultrasound - preliminary results. Eur J Ultrasound 2000;12:9-16.
28. Zulian F, Meneghesso D, Grisan E, Vittadello F, Belloni Fortina A, Pigozzi B, et al. A new computerized method for the assessment of skin lesions in localized scleroderma. Rheumatology 2007;46:856-860 (Pubitemid 47064263)
29. Wolkerstorfer A, de Waard van der Spek FB, Glazenburg EJ, Mulder PG, Oranje AP. Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre-screening tool for studies. Acta Derm Venereol 1999;79:356-359 (Pubitemid 29414967)
30. Guzman J, Burgos-Vargas R, Duarte-Salazar C, Gomez-Mora P. Reliability of the articular examination in children with juvenile rheumatoid arthritis: interobserver agreement and sources of disagreement. J Rheumatol 1995;22:2331-2336
31. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-1285
32. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993;20:1892-1896 (Pubitemid 24031593)
33. Rodnan GP, Lipinski E, Luksick J. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 1979;22:130-140 (Pubitemid 9156666)
34. Furst DE, Clements PJ, Steen VD, Medsger TA Jr, Masi AT, D'Angelo WA, et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 1998;25:84-88
35. Xie Y, Zhang X, Wakasugi S, Makino T, Inoue Y, Ihn H. Immunohistochemical characterization of the cellular infiltrate in localized scleroderma. Int J Dermatol 2008;47:438-442 (Pubitemid 351560306)
36. Foeldvari I, Wierk A. Healthy children have a significantly increased skin score assessed with the modified Rodnan skin score. Rheumatology 2006;45:76-78 (Pubitemid 43033879)
37. Brennan P, Silman A, Black C, Bernstein R, Coppock J, Maddison P, et al. Reliability of skin involvement measures in scleroderma. The UK Scleroderma Study Group. Br J Rheumatol 1992;31:457-460
38. Czirjak L, Nagy Z, Aringer M, Riemekasten G, Matucci-Cerinic M, Furst DE. The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis 2007;66:966-969 Epub 2007 Jan 18. (Pubitemid 46999803)
39. Silman A, Harrison M, Brennan P. Is it possible to reduce observer variability in skin score assessment of scleroderma? The ad hoc International Group on the Assessment of Disease Outcome in Scleroderma. J Rheumatol 1995;22:1277-1280
40. Charman CR, Venn AJ, Williams HC. Measurement of body surface area involvement in atopic eczema: an impossible task? Br J Dermatol 1999;140:109-111
41. Finlay AY. Measurement of disease activity and outcome in atopic dermatitis. Br J Dermatol 1996;135:509-515 (Pubitemid 26340258)
42. Ramsay B, Lawrence CM. Measurement of involved surface area in patients with psoriasis. Br J Dermatol 1991;124:565-570
43. Tiling-Grosse S, Rees J. Assessment of area of involvement in skin disease: a study using schematic figure outlines. Br J Dermatol 1993;128:69-74. (Pubitemid 23030151)
44. Ashcroft DM, Wan Po AL, Williams HC, Griffiths CE. Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol 1999;141:185-191
45. Charman CR, Venn AJ, Williams H. Measuring atopic eczema severity visually: which variables are most important to patients? Arch Dermatol 2005;141:1146-1151
46. Albrecht J, Taylor L, Berlin JA, Dulay S, Ang G, Fakharzadeh S, et al. The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol 2005;125:889-894
47. Charman CR, Venn AJ, Williams HC. Reliability testing of the Six Area, Six Sign Atopic Dermatitis severity score. Br J Dermatol 2002;146:1057-1060
48. Klein RQ, Bangert CA, Costner M, Connolly MK, Tanikawa A, Okawa J, et al. Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis. Br J Dermatol 2008;159:887-894 Epub 2008 Jul 4.
49. Lee CW, Kwon CW, Yoo DH, Kim SY. Linear scleroderma occurring in a patient with systemic lupus erythematosus - short report. J Korean Med Sci 1994;9:197-199
50. Robertson LP, Davies MG, Hickling P. Generalized morphoea in a patient with Felty's syndrome. J Eur Acad Dermatol Venereol 2000;14:191-193 (Pubitemid 32899294)
51. Zannin ME, Martini G, Athreya BH, Russo R, Higgins GC, Vittadello F, et al. Ocular involvement in children with localized scleroderma: a multicenter study. Br J Ophthalmol 2007;91:1311-1314 Epub 2007 May 2
52. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Invest Dermatol 2005;125:659-664
53. Chuh AA, Chan HH. Effect on quality of life in patients with pityriasis rosea: is it associated with rash severity? Int J Dermatol 2005;44:372-377
54. Hon KL, Kam WY, Lam MC, Leung TF, Ng PC. CDLQI, SCORAD and NESS: are they correlated? Qual Life Res 2006;15:1551-1558